Anders Svensson
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Treatment patterns and overall survival among patients with myelodysplastic syndromes treated in the US community oncology setting: a real-world retrospective observational study.
Journal: Leukemia & lymphoma
Published: December 13, 2025
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs).
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 07, 2023
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial.
Journal: Diabetes, obesity & metabolism
Published: June 26, 2019
Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 23, 2017
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
Journal: European heart journal
Published: December 30, 2014
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.
Journal: American heart journal
Published: December 12, 2014
Championing cardiovascular health innovation in Europe.
Journal: Acta cardiologica
Published: March 04, 2014
Large streamlined trials in cardiovascular disease.
Journal: European heart journal
Published: January 04, 2014
Championing cardiovascular health innovation in Europe.
Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
Published: October 30, 2013
Championing cardiovascular health innovation in Europe.
Journal: European heart journal
Published: July 09, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026